Proteinuria in left ventricular assist device candidates: an emerging risk factor for renal failure and mortality

Over the last decade, advances in left ventricular assist device (LVAD) therapy have revolutionized care of advanced heart failure (HF) patients with excellent long-term survival and quality of life. Approval of LVAD in transplant ineligible patients as destination therapy (DT) allowed for broader application of this technology in older and sicker patient populations. Chronic kidney disease (CKD) is among the most prevalent comorbidities in advanced HF due to coexisting intrinsic renal disease and/or adverse hemodynamics.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Source Type: research